AC
Armistice Capital Portfolio holdings
AUM
$2.64B
This Quarter Return
+4.88%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$3.82B
AUM Growth
+$3.82B
(+0.03%)
Cap. Flow
-$255M
Cap. Flow
% of AUM
-6.66%
Top 10 Holdings %
Top 10 Hldgs %
31.93%
Holding
328
New
76
Increased
85
Reduced
65
Closed
72
Top Buys
| 1 |
NARI
Inari Medical, Inc. Common Stock
NARI
|
$33.5M |
| 2 |
FIVE9
FIVN
|
$33.1M |
| 3 |
Domino's
DPZ
|
$32.9M |
| 4 |
Incyte
INCY
|
$28.6M |
| 5 |
Humana
HUM
|
$23.6M |
Top Sells
| 1 |
Neurocrine Biosciences
NBIX
|
$91.8M |
| 2 |
Aligos Therapeutics
ALGS
|
$60.1M |
| 3 |
Exact Sciences
EXAS
|
$59.2M |
| 4 |
Sanofi
SNY
|
$53M |
| 5 |
Keurig Dr Pepper
KDP
|
$49.6M |
Sector Composition
| 1 | Healthcare | 68.01% |
| 2 | Consumer Discretionary | 11.66% |
| 3 | Consumer Staples | 8.76% |
| 4 | Technology | 8.5% |
| 5 | Communication Services | 1.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
PTC Therapeutics
PTCT
$3.92B
| $268M | 4.29% | 7,234,898 +272,671 | +4% | +$10.1M |
|
2
Supernus Pharmaceuticals
SUPN
$2.53B
| $159M | 2.54% | 5,096,000 -176,000 | -3% | -$5.49M |
|
|
3
Incyte
INCY
$16.5B
| $145M | 2.32% | 2,196,105 +432,105 | +24% | +$28.6M |
|
4
Travere Therapeutics
TVTX
$1.56B
| $107M | 1.71% | 7,648,000 +148,000 | +2% | +$2.07M |
|
5
Immunovant
IMVT
$2.56B
| $101M | 1.62% | 3,548,000 +151,091 | +4% | +$4.31M |
|
6
Cytokinetics
CYTK
$4.23B
| $100M | 1.6% | 1,896,575 -169,416 | -8% | -$8.95M |
|
7
Agios Pharmaceuticals
AGIO
$2.19B
| $98.1M | 1.57% | 2,207,070 +127,919 | +6% | +$5.68M |
|
8
Grifois
GRFS
$6.78B
| $84.7M | 1.35% | 9,536,000 +1,644,000 | +21% | +$14.6M |
|
9
argenx
ARGX
$43.6B
| $82.4M | 1.32% | 152,000 -48,000 | -24% | -$26M |
|
|
NARI
10
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $75.1M | 1.2% | 1,822,000 +812,748 | +81% | +$33.5M |
|
11
AB InBev
BUD
$122B
| $72.4M | 1.16% | 1,092,000 +253,000 | +30% | +$16.8M |
|
12
Dentsply Sirona
XRAY
$2.85B
| $71.6M | 1.15% | 2,646,772 +348,772 | +15% | +$9.44M |
|
13
Novo Nordisk
NVO
$251B
| $67.3M | 1.08% | 565,000 +21,000 | +4% | +$2.5M |
|
14
Aurinia Pharmaceuticals
AUPH
$1.58B
| $60.1M | 0.96% | 8,200,000 -2,936,000 | -26% | -$21.5M |
|
15
Biohaven
BHVN
$1.63B
| $59.9M | 0.96% | 1,199,495 -197,473 | -14% | -$9.87M |
|
16
Orthofix Medical
OFIX
$592M
| $58.9M | 0.94% | 3,768,000 +18,000 | +0.5% | +$281K |
|
17
Medtronic
MDT
$119B
| $57.3M | 0.92% | 635,928 -188,583 | -23% | -$17M |
|
|
18
Humana
HUM
$36.5B
| $56.4M | 0.9% | 178,085 +74,391 | +72% | +$23.6M |
|
|
19
FIVE9
FIVN
$2.08B
| $53.9M | 0.86% | 1,876,000 +1,153,418 | +160% | +$33.1M |
|
20
Kura Oncology
KURA
$686M
| $51.9M | 0.83% | 2,658,000 +308,000 | +13% | +$6.02M |
|
21
Simply Good Foods
SMPL
$2.88B
| $49.1M | 0.78% | 1,411,120 +453,957 | +47% | +$15.8M |
|
22
Spectrum Brands
SPB
$1.38B
| $47.1M | 0.75% | 495,000 +55,623 | +13% | +$5.29M |
|
23
Shake Shack
SHAK
$4.27B
| $46.9M | 0.75% | 453,974 -125,930 | -22% | -$13M |
|
24
PENN Entertainment
PENN
$2.95B
| $45.2M | 0.72% | 2,394,310 -248,750 | -9% | -$4.69M |
|
|
BCYC
25
Bicycle Therapeutics
BCYC
$511M
| $44.3M | 0.71% | 1,956,000 -16,000 | -0.8% | -$362K |
|